News

Vaccinogen Announces New Relationship with CRO Clinipace Worldwide

August 14, 2009 – The EMEA classifies OncoVAX® as an Advanced Therapeutic Medicinal Product

August 26, 2009 – Vaccinogen BV passes inspection and receives a new certificate of cGMP.

FDA Approval

Special Protocol Assessment
Learn more >>

Fast Track
Learn more >>

Human Vaccines 2006
Active Specific Immunotherapy with Autologous Tumor Cell Vaccines
Learn more >>

Vaccinogen is uniquely positioned within the cancer vaccine space
Learn more >>